首页> 美国卫生研究院文献>other >Nesfatin-130–59 but not the N- and C-terminal fragments nesfatin-11–29 and nesfatin-160–82 injected intracerebroventricularly decreases dark phase food intake by increasing inter-meal intervals in mice
【2h】

Nesfatin-130–59 but not the N- and C-terminal fragments nesfatin-11–29 and nesfatin-160–82 injected intracerebroventricularly decreases dark phase food intake by increasing inter-meal intervals in mice

机译:nesfatin-130-59但不是Nesfatin-11-29和Nesfatin-160-82通过增加小鼠的膳食间隔来注射颅内腔内的Nesfatin-11-29和Nesfatin-160-82

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Nesfatin-1 is an 82 amino acid N-terminal fragment of nucleobindin2 that was consistently shown to reduce dark phase food intake upon brain injection in rodents. We recently reported that nesfatin-11–82 injected intracerebroventricularly (icv) reduces dark phase feeding in mice. Moreover, intraperitoneal injection of mid-fragment nesfatin-1 (nesfatin-130–59) mimics the food intake-reducing effects of nesfatin-11–82, whereas N-terminal (nesfatin-11–29) and C-terminal fragments (nesfatin-160–82) did not. We therefore characterized the structure-activity relationship of nesfatin-1 injected icv to influence the dark phase meal pattern in mice. Mouse nesfatin-11–29, nesfatin-130–59, nesfatin-160–82 or vehicle was injected icv in freely fed C57Bl/6 mice immediately before the dark phase and food intake was monitored using an automated episodic feeding monitoring system. Nesfatin-130–59 (0.1, 0.3, 0.9 nmol/mouse) induced a dose-related reduction of 4-h food intake by 28%, 49% and 49% respectively resulting in a 23% decreased cumulative 24-h food intake compared to vehicle (p<0.05). The peak reduction occurred during the 3rd (−96%) and 4th hour (−91%) post injection and was associated with a reduced meal frequency (0–4h: −47%) and prolonged inter-meal intervals (3.1-times) compared to vehicle (p<0.05), whereas meal size was not altered. In contrast, neither nesfatin-11–29 nor nesfatin-160–82 reduced dark phase food intake at equimolar doses although nesfatin-160–82 prolonged inter-meal intervals (1.7-times, p<0.05). Nesfatin-130–59 is the active core of nesfatin-11–82 to induce satiety indicated by a reduced meal number during the first 4h post injection. The delayed onset may be indicative of time required to modulate other hypothalamic and medullary networks regulating nocturnal feeding as established for nesfatin-1.
机译:Nesfatin-1是核吲哚突2的82个氨基酸N-末端片段,其始终如一地显示,以减少啮齿动物中脑注射时的黑相食物摄入量。我们最近报道,Nesfatin-11-82注射颅内腔(ICV)减少了小鼠中的黑相饲养。此外,腹膜内注射中间片段Nesfatin-1(Nesfatin-130-59)模拟Nesfatin-11-82的食物摄入降低效果,而N-末端(Nesfatin-11-29)和C末端片段(Nesfatin -160-82)没有。因此,我们的特征在于Nesfatin-1注射ICV的结构 - 活性关系,影响小鼠中的黑暗相粉模式。在使用自动扩展喂养监测系统监测黑阶段和食物摄入之前,在自由喂养C57BL / 6小鼠中,将小鼠Nesfatin-11-29,Nesfatin -130-59,Nesfatin-160-82或载体注射ICV。 Nesfatin-130-59(0.1,0.3,0.9 nmol /小鼠)诱导剂量相关的4-H食物摄入量28%,49%和49%,导致累积24-H食物摄入量减少23%到车辆(P <0.05)。在3 Rd (-96%)和4 th 小时(-91%)后的峰值还原发生在注射后,并与膳食频率降低(0-4h :-47%)和延长的膳食间隔(3.1倍)与载体相比(P <0.05),而膳食尺寸没有改变。相比之下,Nesfatin-11-29和Nesfatin-160-82都不在等摩尔剂量下减少黑相食物摄入量,尽管Nesfatin-160-82延长膳食间隔(1.7倍,P <0.05)。 Nesfatin-130-59是Nesfatin-11-82的活性核心,以诱导在注射后的第一个4H期间通过减少的膳食数表示的饱腹感。延迟发作可以指示调节其他下丘脑和髓质网络调节夜间喂养的其他下丘脑和髓质网络所需的时间。

著录项

相似文献

  • 外文文献
  • 中文文献
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号